Recently, Tata Motors updated its Nexon EV with a 45 kWh battery pack, starting at ₹13.99 lakh. We recently drove it in the city, shared our thoughts. However, it competes with the MG Windsor EV at ...

The board of directors of Tech Mahindra Ltd has recommended Final Dividend of Rs. 30/- per equity share of the face value of ...

Accelya Solutions India Limited has recorded consolidated operating income of Rs. 1,367.55 million for the quarter ended ...

The concerns around the Stelara exclusivity appear overblown. China’s new tariffs just reignited the same market patterns that led to triple- and quadruple-digit wins for Matt Maley. Get the ...

Johnson & Johnson (J&J) has announced that Stelara (ustekinumab) has been approved by the European Commission (EC) to treat moderately to severely active Crohn’s disease (CD) in paediatric patients.

BAT2206, the proposed biosimilar to J&J’s Stelara, is a human monoclonal antibody with a unique mechanism of action that has potential in treating Crohn's disease and ulcerative colitis ...

President Trump’s approval rating in the first quarter of his second term is 45 percent — an increase from the same time frame of his first term, according to a recent Gallup survey.

Johnson & Johnson’s inflammatory disease drug Stelara has been approved in Europe for ulcerative colitis (UC), a new use for the multibillion dollar blockbuster. The European Commission cleared ...

A novel combination therapy offers better outcomes for patients with KRAS G12C metastatic colorectal cancer that have stopped ...